Research and Markets: Proteomics - Global Strategic Business Report Reveals Vital Forecasts up to 2015 and Profiles of 168

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/657e19/proteomics_globa) has announced the addition of the "Proteomics - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Proteomics in US$ Million by the following product segments: Expression Proteomics, Functional Proteomics, and Structural Proteomics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for each region for the period of 2009 through 2015. Also, a six-year historic analysis is provided for these markets.

The report profiles 168 companies including many key and niche players such as ActivX Biosciences, Inc., Adnexus Therapeutics, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Daltonics, Inc., Caliper Life Sciences, Caprion Proteomics, Inc., Digilab Genomic Solutions, Inc., Dionex Corporation, GE Healthcare, Biacore Life Sciences, Geneva Bioinformatics S.A., Human Genome Sciences, Inc., Hybrigenics SA, Life Technologies Corporation, Millipore Corp., PerkinElmer, Inc., Shimadzu Biotech, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Tyrian Diagnostics Ltd., Waters Corp., Xencor Inc., and Zyomyx, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Key Topics Covered:

  • 1 INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
  • 2 GLOBAL MARKET OVERVIEW
  • 3 INDUSTRY COMPETITION
  • 4 PRODUCT AND TECHNOLOGY OVERVIEW
  • 5 OVERVIEW OF PROTEOMICS TECHNOLOGIES
  • 6 END-USE APPLICATION AREAS
  • 7 NEW PRODUCT SOLUTIONS/DEVELOPMENTS
  • 8 PRODUCT INTRODUCTIONS/INNOVATIONS IN RECENT PAST
  • 9 RECENT INDUSTRY ACTIVITY
  • 10 CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER
  • 11 FOCUS ON SELECT KEY PLAYERS
  • 12 GLOBAL MARKET PERSPECTIVE
  • 13 GLOSSARY OF TERMS
  • 14 THE UNITED STATES
  • 15 CANADA
  • 16 JAPAN
  • 17 EUROPE
  • 18 REST OF WORLD

The Companies Mentioned inside this Report include:

  • ActivX Biosciences, Inc (USA)
  • Adnexus Therapeutics (USA)
  • Agilent Technologies, Inc (USA)
  • Bio-Rad Laboratories, Inc
  • Bruker Daltonics, Inc (USA)
  • Caliper Life Sciences (US)
  • Caprion Proteomics, Inc (Canada)
  • Digilab Genomic Solutions, Inc (US)
  • Dionex Corporation (USA)
  • GE Healthcare (United Kingdom)
  • Biacore Life Sciences
  • Geneva Bioinformatics SA (Switzerland)
  • Human Genome Sciences, Inc (USA)
  • Hybrigenics SA (France)
  • Life Technologies Corporation (USA)
  • Millipore Corp (USA)
  • PerkinElmer, Inc (USA)
  • Shimadzu Biotech (Japan)
  • Sigma-Aldrich Corporation (USA)
  • Thermo Fisher Scientific (USA)
  • Tyrian Diagnostics Ltd (Australia)
  • Waters Corp (USA)
  • Xencor Inc (USA)
  • Zyomyx, Inc (USA)

For more information visit http://www.researchandmarkets.com/research/657e19/proteomics_globa



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:   United States  Europe  Asia Pacific  North America

INDUSTRY KEYWORDS:   Health  Biotechnology

MEDIA:

Logo
 Logo

Suggested Articles

Barely two years after paying up $263 million for the ex-Asia rights to BeiGene’s tislelizumab, Celgene is bowing out—to the tune of $150 million.

A University of Pennsylvania team discovered that a protein called TOX helps determine the fate of exhausted T cells in cancer and other diseases.

AstraZeneca is set to spend $630 million on R&D in South Korea over the next five years as part of a wider cooperative agreement.